Loading profile…
Riskpilot
← Back to search
Sign in
Get full access
EL
Emilie Lasson
Chief Executive Officer, NORTHSEA THERAPEUTICS NORWAY AS
NO
4 active roles
Watchlist
Share
Full Risika report
Overview
Companies & roles
Network
Active roles
4
directorships & management
Past roles
0
historical positions
Dissolved companies
0
in directorship history
Career timeline
2025 – now
Chief Executive Officer, NORTHSEA THERAPEUTICS NORWAY AS
2024 – now
Legal Owner, GENETIC ANALYSIS AS
2023 – now
Chairman, LABRIDA AS
2021 – now
Board of Directors, PRE DIAGNOSTICS AS
Personal details
Nationality
NO
Active roles
4 positions
Company
Role
Period
Ownership
Status
NORTHSEA THERAPEUTICS NORWAY AS
CVR 916665202
Management
Chief Executive Officer
Since 2025
—
Active
PRE DIAGNOSTICS AS
CVR 912672492
Board
Board of Directors
Since 2021
—
Active
LABRIDA AS
CVR 998895286
Board
Chairman
Since 2023
—
Active
GENETIC ANALYSIS AS
CVR 993373575
Owner
Legal Owner
Since 2024
0.0%
Active
Co-directors & shared companies
Person
Role
Shared companies
Profile
HH
Hilde Hermansen Steineger
Chief Executive Officer
1
company
View profile
DA
David Alan Fraser
Chairman
1
company
View profile
TS
Tore Skjæret
Board of Directors
1
company
View profile
RA
Robertus Antonius Harmannus De Ree
Chairman
1
company
View profile
EC
Erik Christensen
Legal Owner
1
company
View profile
Company network
Active roles
Emilie Lasson
NORTHSEA THERAPEUTICS NORWAY AS
Chief Executive Officer
PRE DIAGNOSTICS AS
Board of Directors
LABRIDA AS
Chairman
GENETIC ANALYSIS AS
Legal Owner